Figure 4
Figure 4. Transfer of the Fgfr-1−/− phenotype to Fgfr+/− embryoid bodies by conditioned medium. (A) Immunohistochemical staining for CD31 expression in Fgfr-1+/− embryoid bodies kept in Fgfr-1+/−–conditioned medium (CM+/−), Fgfr-1−/− embryoid bodies in basal medium (control), and Fgfr-1+/− embryoid bodies in Fgfr-1−/−–conditioned medium (CM−/−). Note the change in vessel morphology in Fgfr-1+/− embryoid bodies in CM−/−, mimicking that in Fgfr-1−/− embryoid bodies. Bottom row of panels shows representative magnifications of the top panels. Bars represent 100 μm. (B) Real-time PCR analyses of Cd31, Vegfr2, and Cd41 transcript levels in embryoid bodies cultured as indicated. (C) Immunostaining for CD41 in Fgfr-1+/− embryoid bodies kept in basal medium (control) or in CM−/−. Bars represent 100 μm. (D) Quantification of CD41+ area showed significantly lower expression of CD41 in Fgfr-1+/− embryoid bodies cultured in CM−/− compared with the regular culture medium (control). *P = .005.

Transfer of the Fgfr-1−/− phenotype to Fgfr+/− embryoid bodies by conditioned medium. (A) Immunohistochemical staining for CD31 expression in Fgfr-1+/− embryoid bodies kept in Fgfr-1+/−–conditioned medium (CM+/−), Fgfr-1−/− embryoid bodies in basal medium (control), and Fgfr-1+/− embryoid bodies in Fgfr-1−/−–conditioned medium (CM−/−). Note the change in vessel morphology in Fgfr-1+/− embryoid bodies in CM−/−, mimicking that in Fgfr-1−/− embryoid bodies. Bottom row of panels shows representative magnifications of the top panels. Bars represent 100 μm. (B) Real-time PCR analyses of Cd31, Vegfr2, and Cd41 transcript levels in embryoid bodies cultured as indicated. (C) Immunostaining for CD41 in Fgfr-1+/− embryoid bodies kept in basal medium (control) or in CM−/−. Bars represent 100 μm. (D) Quantification of CD41+ area showed significantly lower expression of CD41 in Fgfr-1+/− embryoid bodies cultured in CM−/− compared with the regular culture medium (control). *P = .005.

Close Modal

or Create an Account

Close Modal
Close Modal